PHARMACEUTICALS: OIG Makes The Case For Drug Pricing Change
Federal investigators taking a closer look at pharma industry.
The HHS Office of Inspector General has tallied a record recovery for the first half of fiscal year 2004, according to its semiannual report to Congress. The watchdog agency recouped $4 billion more than last year, and finalized some of the largest provider settlements to date.
But the OIG says when patching major leaks in the federal healthcare program, drug makers could be the next big fiscal Band-Aid.
In the report issued June 1, the OIG says that continuing studies and investigations into pricing problems and widespread compliance breaches in...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.